Humacyte, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 495K | 467K | 753K | 301K | 517K | 7.2M | 0 | 0 |
| Cost of Goods Sold | 2.0M | 10.9M | 2.1M | 2.1M | 2.0M | 3.6M | 1.8M | 1.8M |
| Gross Profit | -1.5M | -10.4M | -1.4M | -1.8M | -1.5M | 3.6M | -1.8M | -1.8M |
| R&D Expenses | 19.5M | 14.6M | 17.3M | 22.0M | 15.4M | 20.7M | 22.9M | 23.8M |
| Operating Expenses | 27.4M | 20.4M | 23.0M | 28.0M | 21.7M | 31.7M | 28.4M | 27.7M |
| Operating Income | -28.9M | -30.8M | -24.4M | -29.7M | -23.2M | -28.1M | -30.2M | -29.5M |
| Other Income / Gains | 11.3M | 6.0M | 6.9M | -7.9M | 62.3M | 7.1M | -9.0M | -27.2M |
| Net Income | -17.6M | -24.8M | -17.5M | -37.7M | 39.1M | -20.9M | -39.2M | -56.7M |
| EPS (Diluted) | -0.089 | -0.15 | -0.11 | -0.24 | 0.28 | -0.16 | -0.33 | -0.48 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -3.117 | -22.276 | -1.822 | -5.887 | -2.828 | 0.50 | 0 | 0 |
| General And Administrative Expenses | 7.9M | 0 | 0 | 7.8M | 8.1M | 7.4M | 7.3M | 5.7M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 3.6M | 0 | -1.8M |
| Selling General And Administrative Expenses | 7.9M | 5.8M | 5.7M | 7.8M | 8.1M | 11.0M | 7.3M | 3.9M |
| Other Expenses | 0 | 0 | 0 | -1.9M | -1.8M | 0 | -1.8M | 0 |
| Cost And Expenses | 29.4M | 31.3M | 25.1M | 30.0M | 23.7M | 35.3M | 30.2M | 29.5M |
| Interest Income | 330K | 503K | 590K | 832K | 662K | 852K | 911K | 1.3M |
| Interest Expense | 2.3M | 3.1M | 2.6M | 2.5M | 3.0M | 2.5M | 2.4M | 2.5M |
| Depreciation And Amortization | 1.8M | 1.8M | 1.9M | 1.9M | 1.8M | 1.8M | 1.8M | 1.8M |
| Ebitda | -13.6M | -19.9M | -13.0M | -33.3M | 44.0M | -16.6M | -35.0M | -52.3M |
| Ebitdaratio | -27.39 | -42.662 | -17.308 | -110.475 | 85.05 | -2.30 | 0 | 0 |
| Operating Income Ratio | -58.455 | -66.03 | -32.39 | -98.761 | -44.843 | -3.886 | 0 | 0 |
| Income Before Tax | -17.6M | -24.8M | -17.5M | -37.7M | 39.1M | -20.9M | -39.2M | -56.7M |
| Income Before Tax Ratio | -35.594 | -53.113 | -23.254 | -125.11 | 75.704 | -2.897 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -35.594 | -53.113 | -23.254 | -125.11 | 75.704 | -2.897 | 0 | 0 |
| Epsdiluted | -0.089 | -0.15 | -0.11 | -0.24 | 0.28 | -0.16 | -0.33 | -0.48 |
| Weighted Average Shs Out | 197.8M | 158.2M | 158.3M | 155.4M | 131.5M | 118.5M | 119.4M | 119.2M |
| Weighted Average Shs Out Dil | 197.8M | 158.2M | 158.3M | 155.4M | 131.8M | 118.5M | 119.4M | 119.2M |